Intuitive Surgical Inc
ISRG494.610USD
-12.440-2.45%
Handelsschluss 04/03, 16:00（ET）Kurse um 15 Minuten verzögert
176.38BMarktkapitalisierung
75.94KGV TTM
mehr Informationen über Intuitive Surgical Inc Unternehmen
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Unternehmensinformationen
Unternehmens-codeISRG
Name des UnternehmensIntuitive Surgical Inc
IPO-datumJun 13, 2000
Gegründet am1995
CEODr. Gary S. Guthart, Ph.D.
Anzahl der mitarbeiter15638
WertpapierartOrdinary Share
GeschäftsjahresendeJun 13
Addresse1020 Kifer Road
StadtSUNNYVALE
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl94086
Telefon14085232100
Websitehttps://www.intuitive.com/en-us/about-us/company
Unternehmens-codeISRG
IPO-datumJun 13, 2000
Gegründet am1995
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.27M
+1.05%
Mr. David J. Rosa
Mr. David J. Rosa
President, Director
President, Director
231.87K
+5.81%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
26.16K
+3.17%
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
12.28K
--
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
2.37K
--
Mr. Mark Preston Brosius
Mr. Mark Preston Brosius
Senior Vice President, Chief Manufacturing and Supply Chain Officer
Senior Vice President, Chief Manufacturing and Supply Chain Officer
2.04K
-54.69%
Dr. Monica P. Reed, M.D.
Dr. Monica P. Reed, M.D.
Independent Director
Independent Director
1.61K
--
Dr. Amy L. Ladd, M.D.
Dr. Amy L. Ladd, M.D.
Independent Director
Independent Director
671.00
-18.27%
Ms. Sreelakshmi Kolli
Ms. Sreelakshmi Kolli
Independent Director
Independent Director
240.00
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.27M
+1.05%
Mr. David J. Rosa
Mr. David J. Rosa
President, Director
President, Director
231.87K
+5.81%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
26.16K
+3.17%
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
12.28K
--
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
2.37K
--
Umsatzaufteilung
Währung: USDUpdate-Zeit: Wed, Apr 2
Währung: USDUpdate-Zeit: Wed, Apr 2
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Instruments and accessories
5.08B
60.81%
Systems
1.97B
23.54%
Services
1.31B
15.65%
Nach RegionUSD
Name
Umsatz
Anteil
U.S.
5.59B
66.92%
Outside of United states
2.76B
33.08%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Instruments and accessories
5.08B
60.81%
Systems
1.97B
23.54%
Services
1.31B
15.65%
Aktionäre
Update-Zeit: Fri, Feb 21
Update-Zeit: Fri, Feb 21
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
8.95%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Global Advisors (US)
4.27%
T. Rowe Price Associates, Inc.
3.90%
Fidelity Management & Research Company LLC
2.93%
Other
74.77%
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
8.95%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Global Advisors (US)
4.27%
T. Rowe Price Associates, Inc.
3.90%
Fidelity Management & Research Company LLC
2.93%
Other
74.77%
Art
Aktionäre
Anteil
Investment Advisor
43.07%
Investment Advisor/Hedge Fund
35.61%
Bank and Trust
2.46%
Research Firm
2.40%
Pension Fund
2.20%
Hedge Fund
1.76%
Sovereign Wealth Fund
1.39%
Individual Investor
0.50%
Foundation
0.15%
Other
10.46%
Institutionelle Beteiligung
Update-Zeit: Sun, Jan 19
Update-Zeit: Sun, Jan 19
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
3377
322.64M
90.05%
-654.22K
2024Q4
3426
322.11M
90.31%
-1.17M
2024Q3
3255
319.27M
89.84%
-8.25M
2024Q2
3152
322.86M
91.02%
+572.17K
2024Q1
3116
317.58M
89.60%
-829.16K
2023Q4
3055
314.33M
89.27%
-2.70M
2023Q3
2961
312.82M
89.02%
-3.61M
2023Q2
2932
311.78M
88.97%
-2.17M
2023Q1
2848
309.16M
88.25%
-6.75M
2022Q4
2840
310.11M
87.74%
-7.77M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
32.06M
8.95%
+364.96K
+1.15%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
18.57M
5.18%
+488.70K
+2.70%
Dec 31, 2024
State Street Global Advisors (US)
15.31M
4.27%
+255.30K
+1.70%
Dec 31, 2024
T. Rowe Price Associates, Inc.
13.96M
3.9%
-133.51K
-0.95%
Dec 31, 2024
Fidelity Management & Research Company LLC
10.49M
2.93%
-117.40K
-1.11%
Dec 31, 2024
Geode Capital Management, L.L.C.
7.76M
2.17%
+243.80K
+3.25%
Dec 31, 2024
Capital World Investors
7.43M
2.07%
+11.93K
+0.16%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
7.37M
2.06%
+98.84K
+1.36%
Feb 28, 2025
JP Morgan Asset Management
7.22M
2.01%
+123.15K
+1.74%
Dec 31, 2024
Fisher Investments
4.87M
1.36%
+86.49K
+1.81%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Tue, Apr 1
Update-Zeit: Tue, Apr 1
Name
Anteil
Langar Global HealthTech ETF
19.52%
iShares U.S. Medical Devices ETF
16.03%
Global X Robotics & Artificial Intelligence ETF
11.55%
First Trust Nasdaq Lux Digi Health Solutions ETF
8.42%
Invesco AI and Next Gen Software ETF
7.04%
Franklin Intelligent Machines ETF
6.73%
Goldman Sachs Future Health Care Equity ETF
6.3%
Neuberger Berman Disrupters ETF
6.01%
Inspire 100 ETF
5.52%
iShares Health Innovation Active ETF
5.34%
Mehr Anzeigen
Langar Global HealthTech ETF
Anteil19.52%
iShares U.S. Medical Devices ETF
Anteil16.03%
Global X Robotics & Artificial Intelligence ETF
Anteil11.55%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil8.42%
Invesco AI and Next Gen Software ETF
Anteil7.04%
Franklin Intelligent Machines ETF
Anteil6.73%
Goldman Sachs Future Health Care Equity ETF
Anteil6.3%
Neuberger Berman Disrupters ETF
Anteil6.01%
Inspire 100 ETF
Anteil5.52%
iShares Health Innovation Active ETF
Anteil5.34%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Aug 05, 2021
Split
1>3
Datum
Art
Verhältnis
Aug 05, 2021
Split
1>3